News List

Progress in the development of new and efficient diabetes treatment drugs

Recently, Wang Junfeng's research team from Hefei Institute of Material Science, Chinese Academy

FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S.

Merck's new HIV drug Pedro (Doravirin) was approved in China

Merck announced recentlythat its new HIV drug Pedro (doravirin tablets) has been officially approved

ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shion

European Commission Grants Marketing Authorization for Jyseleca® ▼ (Filgotinib) for the Treatment of Adults With Moderate to Severe Active Rheumatoid Arthritis

Gilead Sciences and Galapagos NV today announced that the European Commission (EC) has granted marke

Gastrointestinal stromal tumor (GIST) targeted new drugs! Avapritinib will be approved in the EU in September

Blueprint Medicines announced that the European Medicines Agency (EMA) Committee for Medicinal Produ

Gilead's Veklury has been approved:Veklury is the First Approved Treatment Option for COVID-19 in the European Union

At present,The COVID-19 epidemic continues to spread rapidly around the world. As of 01am, July 04,